Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications

NCT00001409 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
HIV Infection

Interventions

DRUG: Interleukin-2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)